annb0t
Top 20
Mesoblast Limited
NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the fourth quarter and full-year ended June 30, 2022.
The webcast will begin at 6.30pm EDT, Tuesday, August 30; 8.30am AEST, Wednesday, August 31, 2022. It can be accessed via: https://webcast.openbriefing.com/8875/
The archived webcast wi...
>>> Read more: Mesoblast Corporate Update and Financial Results Webcast
NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the fourth quarter and full-year ended June 30, 2022.
The webcast will begin at 6.30pm EDT, Tuesday, August 30; 8.30am AEST, Wednesday, August 31, 2022. It can be accessed via: https://webcast.openbriefing.com/8875/
The archived webcast wi...
>>> Read more: Mesoblast Corporate Update and Financial Results Webcast
